Latest Australian Government News

Parkway Corporate Limited delivered a record $5.21 million quarterly revenue and $0.73 million EBITDA in Q3 FY26, driven by ramp-up of a major water infrastructure project. Meanwhile, its flagship Queensland Brine Management Complex progresses through key development application milestones with public notification underway.

Strategic Elements Ltd (ASX:SOR) advanced its Energy Ink™ technology and commenced a pilot deployment of its EdgeiQ system at a WA gold mine, while maintaining a solid cash position of A$2.87 million and no debt.

Bass Oil’s March quarter saw a 13% production dip due to Cooper Basin rains but secured key gas field acquisitions, a $3.5 million grant, and completed a $3 million capital raise.

Etherstack has smashed its first half revenue record for FY26 with strong government contract deliveries, prompting an upward revision of full-year revenue guidance to as much as US$18.9 million.

Catalina Resources has broadened its exploration footprint at Beasley Creek, unveiling multiple new copper-gold-silver targets along a key structural corridor and securing $180,000 in Western Australian government funding to kickstart drilling.

NH3 Clean Energy has marked strong progress in its WAH2 clean ammonia project by appointing Linde Engineering for FEED and securing a 15-year water supply agreement, setting the stage for a final investment decision by year-end.

Galan Lithium has completed Phase 1 construction at Hombre Muerto West, secured A$40 million to expand production capacity by 30%, and is poised to begin lithium chloride concentrate shipments in H2 2026.

BPM Minerals has completed key surveys at its Bonnie & Clyde Prospect within the Forelands Gold Project, setting the stage for maiden drilling in Q3 2026. The project’s geological complexity and strong geochemical anomalies underline its potential for a major gold discovery.

Cauldron Energy has won two co-funded grants totaling up to AUD 217,750 from the WA Government’s Exploration Incentive Scheme to advance uranium exploration at its Yanrey Project, targeting key palaeochannels including the high-priority Curtis channel.

Island Pharmaceuticals has cleared a major regulatory hurdle with the US FDA, confirming a clinical development path for its antiviral Galidesivir under the Animal Rule. Backed by a $9 million capital raise and strategic partnerships, the company is poised for potential US government procurement and biodefence market entry.

AML3D has maintained a steady $2.2 million quarterly revenue run rate and secured $12.5 million in new orders during 3Q26, pushing its total orders for FY2026 to $29 million. The company is aggressively expanding its US manufacturing footprint and making initial inroads into UK and European defence markets.

Alliance Nickel is pursuing capital cost savings at its NiWest Nickel-Cobalt Project through vat leaching trials while reporting promising gold assay results from initial drilling at Australia United. A $4.15 million entitlement offer aims to fund these efforts amid ongoing offtake renegotiations with Stellantis.